Anti-Cancer Drugs Journal Issues Research Articles in January 2023 Edition
December 26, 2022
December 26, 2022
LONDON, England, Dec. 26 -- Anti-Cancer Drugs, a journal that says it reports clinical and experimental results related to anti-cancer drugs and welcomes contributions on anti-cancer drug design, drug delivery, pharmacology, hormonal and biological modalities and chemotherapy evaluation, published research articles on the following topics in its January 2023 edition:
Preclinical Reports:
* MYBPC1 is a key regulator for laryngeal carcinoma formation
* Appli . . .
Preclinical Reports:
* MYBPC1 is a key regulator for laryngeal carcinoma formation
* Appli . . .